ADO 6.90% 2.7¢ anteotech ltd

I look at this slightly differentlyI think our Covid test will...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 406 Posts.
    lightbulb Created with Sketch. 964
    I look at this slightly differently

    I think our Covid test will open doors for us for future tests

    But Eugeni as a "Platform" I think is slightly oversold (if this this possible if we haven't sold anything)

    Customers will be getting the reader for free if they buy enough tests.

    And Eugeni itself is really just a rebadged Axxin device , slightly modified (Toyota charading as a Lexus anyone )

    And Abbot are also working with Axxin with their Reader as well .....

    Selling a Sepsis Test for a Eugeni reader may be easier with the door opened by our Covid test , but If Abbot or anyone else develops a Better Test then our "Platform" will end up in the trash basket.

    We need to develop THE BEST TEST POSSIBLE for each medical need as they will all be judged independently.

    Covid is here right now and will be 5 year + opportunity so we need to take advantage.

    It will provide cashflow to market our "forever tests" , SEPSIS , TROPONIN , etc etc

    Let's hope all those scientists we have been hiring are hard at it !!

 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.